Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
10.38
-0.10 (-0.95%)
At close: Mar 28, 2025, 4:00 PM
10.30
-0.08 (-0.76%)
Pre-market: Mar 31, 2025, 8:41 AM EDT
Roivant Sciences Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Roivant Sciences stock have an average target of 17.1, with a low estimate of 12.5 and a high estimate of 22. The average target predicts an increase of 64.74% from the current stock price of 10.38.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 11, 2025.
Analyst Ratings
The average analyst rating for Roivant Sciences stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 4 | 3 |
Buy | 4 | 4 | 4 | 4 | 3 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 10 | 10 | 10 | 8 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +73.41% | Feb 11, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +73.41% | Nov 13, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 19, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +73.41% | Sep 19, 2024 |
B of A Securities | B of A Securities | Hold Maintains $12 → $13 | Hold | Maintains | $12 → $13 | +20.42% | Sep 11, 2024 |
Financial Forecast
Revenue This Year
96.24M
from 124.80M
Decreased by -22.88%
Revenue Next Year
28.63M
from 96.24M
Decreased by -70.25%
EPS This Year
-0.36
from 5.23
EPS Next Year
-1.28
from -0.36
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | 156.0M | 63.0M | 163.8M | |||
Avg | 96.2M | 28.6M | 69.2M | |||
Low | 73.1M | 7.0M | 23.5M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | 25.0% | -34.5% | 472.1% | |||
Avg | -22.9% | -70.2% | 141.5% | |||
Low | -41.4% | -92.8% | -17.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | -0.13 | -1.08 | -1.22 | |||
Avg | -0.36 | -1.28 | -1.31 | |||
Low | -0.66 | -1.43 | -1.42 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.